What Will the Next Healthcare Exit Winners Look Like? – MedCity News
Today’s exit market for healthcare companies is in a sorting phase, according to one expert. Jack Euston — a longtime…
Today’s exit market for healthcare companies is in a sorting phase, according to one expert. Jack Euston — a longtime…
Engineered viruses are a mainstay in genetic medicine due to their ability to ferry genetic cargo into cells. But limitations…
A new healthcare-focused investment firm launched on Tuesday with support from Nueterra Capital. It’s seeking to help startups navigate the…
When a biotech startup reveals a substantial round of funding, the announcement typically includes information about a pipeline, or at…
Rosarium Health, a company enabling aging at home, has raised $6 million in seed funding and secured partnerships with several…
From how deals get sourced to how capital allocators think, generative AI is reshaping how venture capital works. For many,…
About 12% of claims were denied in 2024, leading to $262 billion in lost revenue to providers. Providers spend about…
Tortugas Neuroscience launched from stealth Tuesday with $106 million to support a pipeline of four in-licensed drugs in clinical development…
In a cell, the nucleus and related genetic material are housed inside a double-layered membrane. Scientists previously thought this nuclear…
Antibody drug conjugates continue to be a robust area for research and dealmaking, and Eli Lilly’s latest move in this…
After several uneven years for venture funding, the digital health sector saw a boost in investment during the first quarter…
Katie Jacobs Stanton took an unusual and accidental path to becoming a healthcare investor. After building products at Yahoo and…
Flourish Care, a maternal healthcare platform, has raised $5.7 million in seed funding to scale its doula network, the startup…
San Diego-based startup Turquoise Health closed a $40 million Series C financing round on Tuesday, bringing the company’s overall fundraising…
Cancer treatment is evolving with a growing number of therapies designed to address specific targets expressed by tumors or genetic…
When Vima Therapeutics launched last year to take its drug candidate into human testing, the lead indication was isolated dystonia,…
Many healthcare AI startups are changing the way they charge for their technology, moving away from flat subscription rates and…
Atavistik Bio has raised an additional $40 million as the startup prepares for clinical testing of a drug in development…